Global Generic Drug Research and Development Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Generic Drug Research and Development Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Generic Drug Research and Development Services refers to a service that supports pharmaceutical companies in the process of developing generic drugs. It involves a range of activities and expertise aimed at obtaining regulatory approval for a generic version of a brand-name drug. The service typically includes activities such as formulation development, preclinical studies, bioequivalence testing, clinical trial design and execution, regulatory strategy development, and submission preparation. The service provider may also offer project management and regulatory affairs support throughout the development process. The goal of Generic Drug Development Service is to assist pharmaceutical companies in developing generic drugs that are equivalent to the reference product in terms of dosage form, strength, route of administration, quality, safety, and efficacy. This involves demonstrating bioequivalence through rigorous testing and analysis. By utilizing a Generic Drug Development Service, pharmaceutical companies can streamline the drug development process, reduce costs, and ensure compliance with regulatory requirements. These services can be particularly beneficial for smaller pharmaceutical companies or those with limited in-house capabilities in drug development and regulatory affairs.
Generic Drug Research and Development Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Generic Drug Research and Development Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Government & Regulatory Agencies and Pharmaceutical Company are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Generic Drug Research and Development Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Generic Drug Research and Development Services key companies include PDG, Navitas Life Sciences, Teva, Avivia, Aavis Pharmaceuticals, CRS, Eurofins, Veeda CRO and JOINN, etc. PDG, Navitas Life Sciences, Teva are top 3 players and held % share in total in 2022.
Generic Drug Research and Development Services can be divided into On-line Services and Off-line Services, etc. On-line Services is the mainstream product in the market, accounting for % share globally in 2022.
Generic Drug Research and Development Services is widely used in various fields, such as Government & Regulatory Agencies, Pharmaceutical Company, Academic Centre and CRO, etc. Government & Regulatory Agencies provides greatest supports to the Generic Drug Research and Development Services industry development. In 2022, global % share of Generic Drug Research and Development Services went into Government & Regulatory Agencies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Generic Drug Research and Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
PDG
Navitas Life Sciences
Teva
Avivia
Aavis Pharmaceuticals
CRS
Eurofins
Veeda CRO
JOINN
Tigermed
PHARMARON
DiQi Pharmaceuticals Co, Ltd.
AUSUN PHARM
Beijing Honghui Meditech Co., Ltd.
HiCrystal
MEDICILON
Duo Rul Pharmaceutlcal Co..Ltd
TI Group
TIANHENG
BIOGINGLAM
XINYAO
HIPHAR MEDICAL
NKD PHARM CO, LTD
WuXi AppTec
Segment by Type
On-line Services
Off-line Services
Government & Regulatory Agencies
Pharmaceutical Company
Academic Centre
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Generic Drug Research and Development Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Generic Drug Research and Development Services introduction, etc. Generic Drug Research and Development Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Generic Drug Research and Development Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Generic Drug Research and Development Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Generic Drug Research and Development Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Government & Regulatory Agencies and Pharmaceutical Company are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Generic Drug Research and Development Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Generic Drug Research and Development Services key companies include PDG, Navitas Life Sciences, Teva, Avivia, Aavis Pharmaceuticals, CRS, Eurofins, Veeda CRO and JOINN, etc. PDG, Navitas Life Sciences, Teva are top 3 players and held % share in total in 2022.
Generic Drug Research and Development Services can be divided into On-line Services and Off-line Services, etc. On-line Services is the mainstream product in the market, accounting for % share globally in 2022.
Generic Drug Research and Development Services is widely used in various fields, such as Government & Regulatory Agencies, Pharmaceutical Company, Academic Centre and CRO, etc. Government & Regulatory Agencies provides greatest supports to the Generic Drug Research and Development Services industry development. In 2022, global % share of Generic Drug Research and Development Services went into Government & Regulatory Agencies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Generic Drug Research and Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
PDG
Navitas Life Sciences
Teva
Avivia
Aavis Pharmaceuticals
CRS
Eurofins
Veeda CRO
JOINN
Tigermed
PHARMARON
DiQi Pharmaceuticals Co, Ltd.
AUSUN PHARM
Beijing Honghui Meditech Co., Ltd.
HiCrystal
MEDICILON
Duo Rul Pharmaceutlcal Co..Ltd
TI Group
TIANHENG
BIOGINGLAM
XINYAO
HIPHAR MEDICAL
NKD PHARM CO, LTD
WuXi AppTec
Segment by Type
On-line Services
Off-line Services
Segment by Application
Government & Regulatory Agencies
Pharmaceutical Company
Academic Centre
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Generic Drug Research and Development Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Generic Drug Research and Development Services introduction, etc. Generic Drug Research and Development Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Generic Drug Research and Development Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices